CU20130127A7 - Modulación de la expresión del transductor de señales y activador de la transcripción 3 (stat3) - Google Patents
Modulación de la expresión del transductor de señales y activador de la transcripción 3 (stat3)Info
- Publication number
- CU20130127A7 CU20130127A7 CU2013000127A CU20130127A CU20130127A7 CU 20130127 A7 CU20130127 A7 CU 20130127A7 CU 2013000127 A CU2013000127 A CU 2013000127A CU 20130127 A CU20130127 A CU 20130127A CU 20130127 A7 CU20130127 A7 CU 20130127A7
- Authority
- CU
- Cuba
- Prior art keywords
- expression
- stat3
- modulation
- signal transducer
- transcription activator
- Prior art date
Links
- 239000012190 activator Substances 0.000 title 1
- 230000035897 transcription Effects 0.000 title 1
- 238000013518 transcription Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000004495 STAT3 Transcription Factor Human genes 0.000 abstract 1
- 108010017324 STAT3 Transcription Factor Proteins 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se describen en la presente compuestos antisentido y métodos para disminuir la expresión de ARNm y proteínas STAT3. Dichos métodos, compuestos y composiciones son de utilidad para tratar, prevenir o aliviar enfermedades hiperproliferativas.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161471045P | 2011-04-01 | 2011-04-01 | |
| US201161558316P | 2011-11-10 | 2011-11-10 | |
| PCT/US2012/031642 WO2012135736A2 (en) | 2011-04-01 | 2012-03-30 | Modulation of signal transducer and activator of transcription 3 (stat3) expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CU20130127A7 true CU20130127A7 (es) | 2014-01-29 |
| CU24088B1 CU24088B1 (es) | 2015-03-30 |
Family
ID=52394793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU2013000127A CU24088B1 (es) | 2011-04-01 | 2012-03-30 | Oligonucleótido de cadena simple inhibidor de la proteína stat3 |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU24088B1 (es) |
-
2012
- 2012-03-30 CU CU2013000127A patent/CU24088B1/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CU24088B1 (es) | 2015-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP13012909A (es) | Modulación de la expresión del transductor de señales y activador de la transcripción 3 (stat3) | |
| CY1122480T1 (el) | Μεθυλικη βαρδοξολονη για τη θεραπεια παχυσαρκιας | |
| AU2018260809A1 (en) | Compounds and uses thereof for the modulation of hemoglobin | |
| AU2018260808A1 (en) | Compounds and uses thereof for the modulation of hemoglobin | |
| MX2016014140A (es) | Composiciones y metodos para modular la expresion de pkk. | |
| MX2018010427A (es) | Formas solidas de un inhibidor de tienopirimidindiona acetil coa carboxilasa y metodos para su produccion. | |
| TN2013000378A1 (en) | Anti - sclerostin antibody crystals and formulations thereof | |
| EP4036240A3 (en) | Transduction buffer | |
| EP3715457A3 (en) | Modulation of prekallikrein (pkk) expression | |
| MX2021001169A (es) | Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas. | |
| EP3329919A8 (en) | Acc inhibitors and uses thereof | |
| MX2015015421A (es) | Inhibidores de acetil-coa carboxilasa (acc) y usos de los mismos. | |
| EA201270100A1 (ru) | Пиримидиноны в качестве ингибиторов pi3k | |
| MX2015015417A (es) | Inhibidores de acetil-coa carboxilasa (acc) y usos de los mismos. | |
| BR112013014119A8 (pt) | Novos moduladores e métodos de uso | |
| PH12014500904B1 (en) | Antibody formulations and methods | |
| EA201170160A1 (ru) | Новые ингибиторы пролиферации и активации переносчика сигнала и активатора транскрипции (stats) | |
| EA201592238A1 (ru) | Ингибиторы протеинкиназы pi3k, в частности ингибиторы pi3k дельта и/или гамма | |
| AU2014230812A8 (en) | Process for making benzoxazepin compounds | |
| UY34070A (es) | Método y composición para tratamiento de semillas. | |
| UY34543A (es) | Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica. | |
| PH12015502577B1 (en) | Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing | |
| MX377276B (es) | Profármacos de antagonista de (s)-1-fenil-2-(piridin-2-il) etanamina (nmda). | |
| CU20130127A7 (es) | Modulación de la expresión del transductor de señales y activador de la transcripción 3 (stat3) | |
| TN2013000055A1 (en) | Heteroaryls and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant of patent |